Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Deciphering Memory and Learning Through Neural Implants for Multi-Region Brain Studies
Published on: April 26, 2024
Application of the DREADD technique in biomedical brain research
Grzegorz Dobrzanski1, Małgorzata Kossut2
1Department of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warszawa, Poland.
Designer Receptors Exclusively Activated by Designer Drugs (DREADD) offers precise control over neural activity. This chemogenetic tool is valuable for brain research and understanding diseases like Parkinson's and addiction.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Chemogenetics provides precise control over neural circuits.
- DREADD technology enables remote manipulation of neuronal activity.
- It has become a key tool alongside optogenetics in neuroscience research.
Purpose of the Study:
- To review the development, biochemistry, and delivery methods of DREADD technology.
- To summarize brain circuit probing approaches using DREADDs.
- To characterize DREADD applications in Parkinson's disease and drug addiction research.
Main Methods:
- Review of DREADD technique history and development.
- Analysis of DREADD biochemistry and receptor expression.
- Summary of brain circuit interrogation strategies using DREADDs.
Main Results:
- DREADD technology allows for selective, remote control of neural activity with high spatial resolution.
- The technique has been widely adopted in basic neuroscience research.
- Significant value demonstrated in preclinical models of Parkinson's disease and drug addiction.
Conclusions:
- DREADD is a powerful chemogenetic tool for neuroscience research.
- Its application extends to understanding and potentially treating neurological and psychiatric disorders.
- Further research can leverage DREADDs for complex brain circuit investigations.
More Related Videos
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
06:39Improving the Application of High Molecular Weight Biotinylated Dextran Amine for Thalamocortical Projection Tracing in the Rat
Published on: April 12, 2018